Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.

A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...